Skip to main content
RT @ericdeinmd: #ACR21 2022 ACR/EULAR MPA Criteria
▶️Classification, NOT diagnostic!
⭐️Clinical: negative for na

Eric Dein ericdeinmd

4 years 10 months ago
#ACR21 2022 ACR/EULAR MPA Criteria ▶️Classification, NOT diagnostic! ⭐️Clinical: negative for nasal GPA symptoms ⭐️Lab: +6 for pANCA or MPO, negative for cANCA/PR3 or eosinophilia @RheumNow https://t.co/6YWmabNzuH https://t.co/XVzBF2KONp
RT @doctorRBC: Elevated CRP levels (>3) in PsA associated with ⬆️risk of cardiovascular events
⭐️NSAID use si

Robert B Chao, MD doctorRBC

4 years 10 months ago
Elevated CRP levels (>3) in PsA associated with ⬆️risk of cardiovascular events ⭐️NSAID use significantly REDUCED risk of CV events Abs#1920 #ACR21 @RheumNow https://t.co/gIz9f4SlWo https://t.co/V4uDeO3Iuz
RT @swethaann23: Racial differences in PsA patients in large US real world database

95% Whites (W) and 5% were AA
NSA

swethaann23 swethaann23

4 years 10 months ago
Racial differences in PsA patients in large US real world database 95% Whites (W) and 5% were AA NSAIDs: 80% W and 78% AAs TNFI: 51% W and 41% of AAs DMARDs: 72% of W and 98% of AAs HTN/DM/Obesity/Gout 🔼 AA Cancer/osteoporosis /anxiety 🔼 whites Abst#1780 #ACR21 @Rheumnow https://t.co/7ee4bVU7ZA
RT @AurelieRheumo: Another study linking long term GC and CV risk in RA!
Medicare data >65yo 130000+ pts
1-year inc

Aurelie Najm AurelieRheumo

4 years 10 months ago
Another study linking long term GC and CV risk in RA! Medicare data >65yo 130000+ pts 1-year incidence CV ⬆️ as follows: 📍Dose ≤5mg 1.4% 📍Dose 5-10mg 1.7% 📍Dose >10mg 1.9% Not replicated in younger pts (Optum data) #ACR21 #Abst1915 @RheumNow https://t.co/DLXdfvfiBW
RT @ericdeinmd: #ACR21 2022 ACR/EULAR EGPA Criteria
▶️Classification, NOT diagnostic!
⭐️Clinical: obstructive ai

Eric Dein ericdeinmd

4 years 10 months ago
#ACR21 2022 ACR/EULAR EGPA Criteria ▶️Classification, NOT diagnostic! ⭐️Clinical: obstructive airway, polyps, MM ⭐️Labs: eosinophilia & extravasc eos-inflamm bx, negative points for Hematuria, cANCA or PR3 - Least sensitive: 85%, but 99% specific @RheumNow https://t.co/6YWmabNzuH https://t.co/kLVqXzNTEf
RT @Janetbirdope: If #dermatomyositis, it is TIFgamma1 that has the high risk of #cancer. If you can order this #AB and

Janet Pope Janetbirdope

4 years 10 months ago
If #dermatomyositis, it is TIFgamma1 that has the high risk of #cancer. If you can order this #AB and it is negative in adults do we need to do cancer screen at baseline? and repeatedly? Need more data. Great observation though. #myositis hub #ACR21 abst#688 @RheumNow https://t.co/zeQl0DACbJ
RT @Yuz6Yusof: #ACR21 #Abstr1908 Potential prognostic biomarker for lymphoma in #sjogren. ISG15 (IFN-I) expression was c

Md Yuzaiful Md Yusof Yuz6Yusof

4 years 10 months ago
#ACR21 #Abstr1908 Potential prognostic biomarker for lymphoma in #sjogren. ISG15 (IFN-I) expression was consistently ⬆️in pts with lymphoma vs none, both in blood and salivary gland biopsy. Work needed re: relation to other markers, ethnicity @RheumNow https://t.co/8VYYEXpXSw https://t.co/ZIkpx5kUfu
RT @AkhilSoodMD: Abst 1916
England & colleagues determined if anti-MAA Ab = predictor of incident RA-ILD
- Anti-MAA

Akhil Sood MD AkhilSoodMD

4 years 10 months ago
Abst 1916 England & colleagues determined if anti-MAA Ab = predictor of incident RA-ILD - Anti-MAA Ab significantly associated w/ incident RA-ILD - Strongly associated w/ higher concentrations anti-MAA - Antibody associations = antigen/isotype dependent #ACR21 @RheumNow https://t.co/z1RspmxBvc https://t.co/hvUm4O6RmX
RT @RichardPAConway: DAS-28 independently associated survival in RA-ILD. As I keep saying, treating the rheumatoid disea

Richard Conway RichardPAConway

4 years 10 months ago
DAS-28 independently associated survival in RA-ILD. As I keep saying, treating the rheumatoid disease properly is the current best strategy for treating RA-ILD. Abstr#1918 #ACR21 @RheumNow #ACRBest https://t.co/FpUK6upyOi
RT @drdavidliew: @Will_I_Am_Osler @zach_wallace_md @RheumNow Very nice, amazingly similar!
- also 3/4 with IgG4 >5xUL

David Liew drdavidliew

4 years 10 months ago
@Will_I_Am_Osler @zach_wallace_md @RheumNow Very nice, amazingly similar! - also 3/4 with IgG4 >5xULN - similar list of other diseases wonderful to have correlation over multiple continents, the beauty of an international meeting like #ACR21! https://t.co/vabBKNbd7u
RT @doctorRBC: Machine learning algorithm demonstrated high level of accuracy (88%) and precision (0.95) in diagnosing p

Robert B Chao, MD doctorRBC

4 years 10 months ago
Machine learning algorithm demonstrated high level of accuracy (88%) and precision (0.95) in diagnosing potential cases of axSpA ⭐️Is there a role for ML to facilitate faster rheum eval for suspicious axSpA cases? Abs#1922 #ACR21 @RheumNow https://t.co/tAPfROPICU https://t.co/HJD37B9jZw
RT @DrMiniDey: Is there a relationship between the weather and RA disease activity?⛈️

#ACR21 Abs#1912
🌡️Temper

Mrinalini Dey DrMiniDey

4 years 10 months ago
Is there a relationship between the weather and RA disease activity?⛈️ #ACR21 Abs#1912 🌡️Temperature & humidity significantly affect pain, TJC & SJC 🌦️PGA was mostly influenced by humidity Should we take the weather into account when assessing patients? @RheumNow https://t.co/e3PewZWkLR
RT @Janetbirdope: RA ILD survival. The ‘smoking’ gun! RA ILD in VA pts mostly menand smokers - data showed disease a

Janet Pope Janetbirdope

4 years 10 months ago
RA ILD survival. The ‘smoking’ gun! RA ILD in VA pts mostly menand smokers - data showed disease activity of #RheumatoidArthritis & ⬆️HAQ both reduced survival independently #ACRBest #ACR21 abst#1918 @RheumNow https://t.co/8GD7rHV07t
Preventive Window of Opportunity in RA? Dr. Aurelie Najm ( @AurelieRheumo) discusses abstract #0455 presented at the #AC

Dr. John Cush RheumNow

4 years 10 months ago
Preventive Window of Opportunity in RA? Dr. Aurelie Najm ( @AurelieRheumo) discusses abstract #0455 presented at the #ACR21 annual meeting. https://t.co/bCN1k5hhUc https://t.co/gpEHk0XIRc
×